Following promising clinical findings , retatrutide, a novel peptide option for treating adult-onset metabolic disorder, has obtained regulatory approval from Great Britain's Drug and Products Agency ( https://amaanvvjy301757.ampedpages.com/retatrutide-compound-peptide-uk-authorization-and-access-68261950